COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 2049: Articles 20481-20490  | Next

A follow-up study shows no new infections caused by patients with repeat positive of COVID-19 in Wuhan
Wu, X., Wang, Z., He, Z., Li, Y., Wu, Y., Wang, H., Liu, Y., Hao, F., Tian, H.
10.1101/2020.11.18.20232892 — Posted: 2020-11-22
A simple direct RT-LAMP SARS-CoV-2 saliva diagnostic
Flynn, M. J., Snitser, O., Yelin, I., Flynn, J., Green, S., Szwarcwort, M., Kishony, R., Elowitz, M. B.
10.1101/2020.11.19.20234948 — Posted: 2020-11-22
Isolation thresholds for curbing SARS-CoV-2 resurgence
Yakob, L.
10.1101/2020.11.20.20235291 — Posted: 2020-11-22
Prevention of severe COVID-19 in the elderly by early high-titer plasma
Libster, R., Perez Marc, G., Wappner, D., Coviello, S., Bianchi, A., Braem, V., Esteban, I., Caballero, M. T., Wood, C. J., Berrueta, M., Rondan, A., Lescano, G., Cruz, P., Ritou, I., Fernandez Vina, V., Alvarez Paggi, D., Esperante, S., Ferretti, A., Ofman, G., Ciganda, A., Rodriguez, R., Lantos, J., Valentini, R., Itcovici, N., Hintze, A., Oyarvide, L., Etchegaray, C., Neira, A., Name, I., Alfonso, J., Lopez Castelo, R., Caruso, G., Rapelius, S., Alvez, F., Etchenique, F. C., Dimase, F., Alvarez, D. R., Aranda, S. S., Sanchez Yanotti, C., DeLuca, J., Jarez Baglivo, S., Laudanno, S. L., Nowogrodzki, F., Izetta, F., Paniguetti, M. T., Fernandez Estrella, P., Gutierrez Meyer, M. E., Dominguez, V., Balduzzi, M., Militerno, R., Ochoa, J., Perez Marc, S., DiNunzio, L., Aizpurua, M., Zadoff, R., Marchionatti, C., Garcia Escude, N., Romero, R., Iraizos, N., Valls, E. E., Rearte Carvalho, P., Franco, J., Estrada, N., Rusconi, J., Ochoa, G., Paz, M. V., Lesch, P., Caracciolo, M. F., Macaneo, M. E., Pocket, L., Marquez, S., Pellegrino, G., Geffner, J., Zarlenga, R., Witteveen, C., Venditti, A., Pichetto Olanda, I., Vargas, J. M., Piani, M., Galnarez, D. C., De la Fuente, F., Gamarnik, A., Nigro, M. d. C., Villaroel, S., Soler Riera, C., Langellotti, L., Taffarel, C., Scapellato, J. L., Girasolli, M., de Zan, M., Riera, J. S., Garcia, E., Rovere, M., Canela, J., Pagella, A., Pampuro, C., Miragaya, Y., Kuperman, S., Raggio, A., Larrea, R. M., Silveyra, M. D., Leberzstein, G., Debonis, A., Molinos, J., Gonzalez, M., Perez, E., Kreplak, N., Pastor Arguello, S., Gibbons, L., Althabe, F., Bergel, E., Polack, F. P.
10.1101/2020.11.20.20234013 — Posted: 2020-11-21
Incidence of SARS-CoV-2 infection among asymptomatic frontline health workers in Los Angeles County, California
Halbrook, M., Gadoth, A., Martin-Blais, R., Grey, A., Contreras, D., Kashani, S., Kazan, C., Kane, B., Tobin, N. H., Fulcher, J. A., Brooker, S. L., Kitchen, S. G., Faure-Kumar, E., Yang, O. O., Ferbas, K. G., Aldrovandi, G. M., Rimoin, A. W.
10.1101/2020.11.18.20234211 — Posted: 2020-11-21
Modeling the frequency and number of persons to test to detect and control COVID-19 outbreaks in congregate settings
Laws, R. L., Paul, P., Mosites, E., Scobie, H., Clarke, K. E. N., Slayton, R. B.
10.1101/2020.11.20.391011 — Posted: 2020-11-20
The Invasive Respiratory Infection Surveillance (IRIS) Initiative reveals significant reductions in invasive bacterial infections during the COVID-19 pandemic
Brueggemann, A. B., Jansen van Rensburg, M. J., Shaw, D., McCarthy, N. D., Jolley, K. A., Maiden, M. C., van der Linden, M. P.
10.1101/2020.11.18.20225029 — Posted: 2020-11-20
Two independent introductions of SARS-CoV-2 into the Iranian outbreak
Fattahi, Z., Mohseni, M., Jalalvand, K., Aghakhani Moghadam, F., Ghaziasadi, A., Keshavarzi, F., Yavarian, J., Jafarpour, A., Mortazavi, S. e., Ghodratpour, F., Behravan, H., Khazeni, M., Momeni, S. A., Jahanzad, I., Moradi, A., Tabarraei, A., Azimi, S. A., Kord, E., Hashemi-Shahri, S. M., Azaran, A., Yousefi, F., Mokhames, Z., Soleimani, A., Ghafari, S., Ziaee, M., Habibzadeh, S., Jeddi, F., Hadadi, A., Abdollahi, A., Kaydani, G. A., Soltani, S., Mokhtari-Azad, T., Najafipour, R., Malekzadeh, R., Kahrizi, K., Jazayeri, S. M., Najmabadi, H.
10.1101/2020.11.16.20229047 — Posted: 2020-11-20 Discussion: Onsite
AI-Driven Multiscale Simulations Illuminate Mechanisms of SARS-CoV-2 Spike Dynamics
Casalino, L., Dommer, A. C., Gaieb, Z., Barros, E. P., Sztain, T., Ahn, S.-H., Trifan, A., Brace, A., Ma, H., Lee, H., Turilli, M., Bogetti, A., Khalid, S., Chong, L., Simmerling, C., Hardy, D., Maia, J., Phillips, J., Kurth, T., Stern, A., Huang, L., McCalpain, J., Tatineni, M., Gibbs, T., Stone, J. E., Jha, S., Ramanathan, A., Amaro, R. E.
10.1101/2020.11.19.390187 — Posted: 2020-11-20 Discussion: Onsite | Offsite
Anti-severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) potency of Mefloquine as an entry inhibitor in vitro
Shionoya, K., Yamasaki, M., Iwanami, S., Ito, Y., Fukushi, S., Ohashi, H., Saso, W., Tanaka, T., Aoki, S., Kuramochi, K., Iwami, S., Takahashi, Y., Suzuki, T., Muramatsu, M., Takeda, M., Wakita, T., Watashi, K.
10.1101/2020.11.19.389726 — Posted: 2020-11-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).